EMD Serono Newsroom

To keep up with the latest news in real-time, subscribe to our email alerts, and follow us on Twitter, Facebook and LinkedIn. If you are a reporter and have questions about the company, please contact us

Latest News

 

Sep 11, 2018

First positive Phase III immunotherapy trial in combination with a tyrosine kinase inhibitor (TKI) in any tumor type Results significant in both PDL1+ and all-comer...

Aug 31, 2018

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, today announced that Rehan Verjee has been appointed President of EMD Serono and Global Head of...

Jul 31, 2018

Rockland, Massachusetts, July 31, 2018 – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, today announced that Cheryl Schwartz joined the...

Jul 30, 2018

Cladribine tablets is an investigational oral therapy with proposed dosing of a maximum of 20 days over two years with no additional dosing required in years 3 and 4 The New Drug Application...

  All Press Releases